STMN1 has been reported to be a prognostic biomarker in several cancers including colorectal cancer [26], esophageal squamous cell carcinoma [16], hepatocellular carcinoma [27], [28], [29], [30] and oral squamous-cell carcinoma [31]. This evidence concerns the gene STMN1 and hepatocellular carcinoma.